Cargando…

The Clinical Relevance of Target Lymph Node Biopsy after Primary Systemic Therapy in Initially Node-Positive Breast Cancer Patients

SIMPLE SUMMARY: Currently, the optimal axillary surgical approach for breast cancer patients with initial node-positive disease and conversion to clinically node-negative status after primary systemic therapy is unclear. The aim of our study was to evaluate the clinical impact of removing the initia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartmann, Steffi, Stachs, Angrit, Schultek, Gesche, Gerber, Bernd, Reimer, Toralf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198475/ https://www.ncbi.nlm.nih.gov/pubmed/34073547 http://dx.doi.org/10.3390/cancers13112620

Ejemplares similares

Radiological Underestimation of Tumor Size as a Relevant Risk Factor for Positive Margin Rate in Breast-Conserving Therapy of Pure Ductal Carcinoma In Situ (DCIS)
por: Schultek, Gesche, et al.
Publicado: (2022)

Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy
por: Hartmann, Steffi, et al.
Publicado: (2021)

Radiopaque tissue transfer and X-ray system versus standard specimen radiography for intraoperative margin assessment in breast-conserving surgery: randomized clinical trial
por: Stachs, Angrit, et al.
Publicado: (2022)

Accuracy of axillary ultrasound in preoperative nodal staging of breast cancer - size of metastases as limiting factor
por: Stachs, Angrit, et al.
Publicado: (2013)

Omission of axillary sentinel lymph node biopsy in early invasive breast cancer
por: Reimer, Toralf
Publicado: (2023)

Distinct Ezrin Truncations Differentiate Metastases in Sentinel Lymph Nodes from Unaffected Lymph Node Tissues, from Primary Breast Tumors, and from Healthy Glandular Breast Tissues
por: Röwer, Claudia, et al.
Publicado: (2017)

The Significance of Preoperative Computed Tomography for Predicting Optimal Cytoreduction in Advanced Ovarian Cancer
por: Stachs, Angrit, et al.
Publicado: (2020)

Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study
por: Hartmann, Steffi, et al.
Publicado: (2023)

Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?
por: Smeets, Ann, et al.
Publicado: (2013)

False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy
por: de Boniface, Jana, et al.
Publicado: (2022)

Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Initial Axillary Lymph Node Metastasis after Primary Systemic Therapy
por: Kang, Eunyoung, et al.
Publicado: (2011)

Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes
por: Kim, S I, et al.
Publicado: (2013)

Avoiding Axillary Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy in Breast Cancer: Rationale for the Prospective, Multicentric EUBREAST-01 Trial
por: Reimer, Toralf, et al.
Publicado: (2020)

Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma
por: Falk Delgado, Alberto, et al.
Publicado: (2019)

Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer
por: Alsumai, Thuraya S, et al.
Publicado: (2022)

Clinical relevance of sentinel lymph node biopsy in early ovarian cancer
por: Seon, Ki Eun, et al.
Publicado: (2023)

Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer
por: Sakae, Chieko, et al.
Publicado: (2016)

Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer [Letter]
por: Zhang, Jia-Yu, et al.
Publicado: (2022)

Sentinel lymph node biopsies in breast cancer
por: Hess, A, et al.
Publicado: (2001)

Sentinel lymph node biopsy in breast cancer
por: Alsaif, Abdulaziz A.
Publicado: (2015)

Sentinel Lymph Node Biopsy in Breast Cancer
por: Mysorekar, Vijaya V.
Publicado: (2010)

A Predictive Model for Nonsentinel Node Status after Sentinel Lymph Node Biopsy in Sentinel Lymph Node-Positive Chinese Women with Early Breast Cancer
por: He, Lifang, et al.
Publicado: (2022)

The Utility of Sentinel Lymph Node Biopsy in Papillary Thyroid Carcinoma with Occult Lymph Nodes
por: Yan, Xingqiang, et al.
Publicado: (2015)

Assessment of sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer in two subgroups: Initially node negative and node positive converted to node negative – A systemic review and meta-analysis
por: Shirzadi, Alireza, et al.
Publicado: (2019)

Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes
por: Aragon-Sanchez, Sofia, et al.
Publicado: (2022)

Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer [Response to Letter]
por: AlSumai, Thuraya S, et al.
Publicado: (2023)

Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management
por: Qiu, Peng-Fei, et al.
Publicado: (2019)

Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer
por: Sarri, Almir José, et al.
Publicado: (2017)

A Longitudinal Comparison of Arm Morbidity in Stage I–II Breast Cancer Patients Treated with Sentinel Lymph Node Biopsy, Sentinel Lymph Node Biopsy Followed by Completion Lymph Node Dissection, or Axillary Lymph Node Dissection
por: Kootstra, Jan J., et al.
Publicado: (2010)

Diagnosis of lymph node metastases by axillary node core biopsy in patients presenting with primary operable breast cancer
por: Damera, A, et al.
Publicado: (2002)

Sparing sentinel node biopsy through axillary lymph node fine needle aspiration in primary breast cancers
por: Cheng, Yu-Shu, et al.
Publicado: (2013)

Lymph node density as a surrogate marker for positive lymph nodes
por: Van Gorp, T, et al.
Publicado: (2011)

Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era
por: Liang, Yue, et al.
Publicado: (2019)

Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis
por: Choi, Hee Jun, et al.
Publicado: (2018)

Sentinel lymph node biopsy in elderly breast cancer
por: Ricciardi, S, et al.
Publicado: (2010)

Mastoscopic sentinel lymph node biopsy in breast cancer
por: Ding, Boni, et al.
Publicado: (2015)

The Prognostic Significance of the Lymph Node Ratio in Axillary Lymph Node Positive Breast Cancer
por: Kim, Ji-Yoon, et al.
Publicado: (2011)

Comparison of clinicopathological characteristics of lymph node positive and lymph node negative breast cancer
por: Hadi, Naila Irum, et al.
Publicado: (2016)

Sentinel Lymph Node Biopsy in Patients With Thick Primary Cutaneous Melanoma
por: Rodriguez Otero, Juan Carlos, et al.
Publicado: (2019)

Cutaneous Melanoma and Sentinel Lymph Node Biopsy
por: van Akkooi, A. C. J., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_m02ll37r8hu13gbrh7kicgbdmv